Wednesday, 29 January 2014 12:20

PM: WILEX AG plans extensive cost-cutting measures

Wednesday, 29 January 2014 12:19

AH: WILEX AG plans extensive cost-cutting measures

Monday, 24 February 2014 12:18

PM: Professor Olaf G. Wilhelm leaves the Executive Management Board on 31 March 2014, Dr Jan Schmidt-Brand will lead the Company

Monday, 24 February 2014 12:18

AH: Professor Olaf G. Wilhelm leaves the Executive Management Board on 31 March 2014, Dr Jan Schmidt-Brand will lead the Company

Tuesday, 25 March 2014 12:17

PM: WILEX will publish the financial results and the Annual Report 2013 on March 31, 2014

Friday, 28 March 2014 12:17

PM: WILEX enters into licensing and development partnership for MESUPRON® in China with Link Health Group

Friday, 28 March 2014 12:16

AH: WILEX enters into licensing and development partnership for MESUPRON® in China with Link Health Group

Monday, 31 March 2014 13:15

PM: WILEX announces financial figures for the 2013 financial year and reports on course of business

Thursday, 10 April 2014 13:15

AH: WILEX AG plans reduction of share capital

Monday, 14 April 2014 13:14

PM: WILEX published 3-Month Financial Report 2014

Wednesday, 30 April 2014 13:14

AH: WILEX and IBA terminate marketing partnership – Global rights to REDECTANE® diagnostic agent revert to WILEX

Wednesday, 21 May 2014 13:13

AH: WILEX returns rights from collaboration in oncology to UCB and UCB waives repayment of the shareholder loan

Monday, 30 June 2014 13:13

PM: WILEX and RedHill Biopharma enter into an exclusive license agreement for MESUPRON®

Monday, 30 June 2014 13:12

AH: WILEX and RedHill Biopharma enter into an exclusive license agreement for MESUPRON®

Tuesday, 15 July 2014 13:12

PM: WILEX AG successfully completes capital reduction

Tuesday, 15 July 2014 13:11

PM: WILEX publishes Half-yearly Financial Report 2014

Thursday, 18 September 2014 13:11

PM: UCB waives repayment of shareholder loan to WILEX

Tuesday, 14 October 2014 13:10

PM: WILEX subsidiary Heidelberg Pharma extends research collaboration with Roche

Tuesday, 14 October 2014 13:10

AH: WILEX subsidiary Heidelberg Pharma extends research collaboration with Roche

Thursday, 15 October 2015 13:09

PM: WILEX publishes 9-month Financial Report 2014

Cookies make it easier for us to provide you with our services. With the usage of our services you permit us to use cookies.